These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3124067

  • 1. Susceptibility of gentamicin sensitive and resistant gram negative bacilli to ceftazidime.
    Bremner DA.
    Pathology; 1987 Jul; 19(3):274-6. PubMed ID: 3124067
    [Abstract] [Full Text] [Related]

  • 2. Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicin.
    Bremner DA.
    Chemotherapy; 1983 Jul; 29(4):283-8. PubMed ID: 6307605
    [Abstract] [Full Text] [Related]

  • 3. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
    Acred P, Ryan DM, Sowa MA, Watts CM.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
    [Abstract] [Full Text] [Related]

  • 4. In-vitro studies with ceftazidime.
    Giamarellou H, Avlami A, Matsakas V, Kosmidis J, Daikos GK.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():73-7. PubMed ID: 19802972
    [Abstract] [Full Text] [Related]

  • 5. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H.
    Am J Med; 1986 Jun 30; 80(6B):126-37. PubMed ID: 3088998
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents.
    Tsuji A, Maniatis A, Bertram MA, Young LS.
    Antimicrob Agents Chemother; 1985 Apr 30; 27(4):515-9. PubMed ID: 3839120
    [Abstract] [Full Text] [Related]

  • 7. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin.
    Neu HC.
    J Antimicrob Chemother; 1981 Sep 30; 8 Suppl B():131-4. PubMed ID: 19810175
    [Abstract] [Full Text] [Related]

  • 8. In-vitro studies with ceftazidime against aerobic gram-negative bacilli and Bacteroides fragilis group.
    Acuna G, Johnston J, Young LS, Martin WJ.
    J Antimicrob Chemother; 1981 Sep 30; 8 Suppl B():83-9. PubMed ID: 19810170
    [Abstract] [Full Text] [Related]

  • 9. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN, Barry AL, Thornsberry C, Gerlach EH, Fuchs PC, Gavan TL, Sommers HM.
    J Antimicrob Chemother; 1981 Sep 30; 8 Suppl B():187-211. PubMed ID: 19802985
    [Abstract] [Full Text] [Related]

  • 10. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
    Norris SM, Guenthner SH, Wenzel RP.
    J Antimicrob Chemother; 1985 Aug 30; 16(2):183-8. PubMed ID: 3934124
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of ceftazidime, cefotaxime and gentamicin against 11,521 clinical isolates of bacteria.
    Steinbakk M, Midtvedt T, Lingaas E, Gardsjord G.
    Acta Pathol Microbiol Immunol Scand B; 1987 Dec 30; 95(6):337-46. PubMed ID: 3326398
    [Abstract] [Full Text] [Related]

  • 12. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
    van Klingeren B.
    J Antimicrob Chemother; 1981 Sep 30; 8 Suppl B():97-105. PubMed ID: 19810171
    [Abstract] [Full Text] [Related]

  • 13. Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels.
    Fung-Tomc J, Dougherty TJ, DeOrio FJ, Simich-Jacobson V, Kessler RE.
    Antimicrob Agents Chemother; 1989 Apr 30; 33(4):498-502. PubMed ID: 2499250
    [Abstract] [Full Text] [Related]

  • 14. Activity of ceftazidime and newer antibiotics against Gram-negative bacilli.
    Schassan HH, Fedder J.
    J Antimicrob Chemother; 1981 Sep 30; 8 Suppl B():79-82. PubMed ID: 19802973
    [Abstract] [Full Text] [Related]

  • 15. In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria.
    Wilkinson LD, Gentry LO.
    J Antimicrob Chemother; 1981 Sep 30; 8 Suppl B():53-6. PubMed ID: 19802969
    [Abstract] [Full Text] [Related]

  • 16. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
    Rouhan D, Le Noc P, Le Noc D.
    Pathol Biol (Paris); 1986 May 30; 34(5):404-9. PubMed ID: 3534713
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
    Pusztai-Markos Z, Pranada F.
    Eur J Clin Microbiol; 1982 Feb 30; 1(1):49-51. PubMed ID: 6293811
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
    Shibl AM, Ishag AH, Durgham SM.
    Chemotherapy; 1989 Feb 30; 35 Suppl 1():72-6. PubMed ID: 2659292
    [Abstract] [Full Text] [Related]

  • 19. The in-vitro activity of ceftazidime compared with that of other cephalosporins.
    Bint AJ, Yeoman P, Kilburn P, Anderson R, Stansfield E.
    J Antimicrob Chemother; 1981 Sep 30; 8 Suppl B():47-51. PubMed ID: 19802968
    [Abstract] [Full Text] [Related]

  • 20. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ, Wang H, China Nosocomial Pathogens Resistance Surveillance Study Group.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):375-81. PubMed ID: 12820912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.